<DOC>
	<DOC>NCT02909114</DOC>
	<brief_summary>Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer</brief_title>
	<detailed_description>Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer, the primary concerns are treatment efficacy and toxicities.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>1875 years Eastern Cooperative Oncology Group (ECOG) performance score ≤ 1 Diagnosis by pathological examination Primary lesion is under control by surgery Adequate blood counts: White blood cell count ≥3.5 x 109/L Haemoglobin levels ≥100g/L Platelet count ≥100 x 109/L Creatinine levels ≤1.0× upper normal limit (UNL) Urea nitrogen levels ≤1.0× upper normal limit (UNL) Alanine aminotransferase (ALT) ≤1.5× upper normal limit (UNL) Aspartate aminotransferase (AST) ≤1.5× upper normal limit (UNL) Alkaline phosphatase (ALP) ≤1.5× upper normal limit (UNL) Total bilirubin (TBIL) ≤1.5× upper normal limit (UNL) Primary lesion is not under control Pancreatic carcinoma Oligometastases could not be located Pregnancy or breast feeding Symptoms or history of peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>stereotactic boday radiotherapy, oligometastases</keyword>
</DOC>